Brief: Teleflex Announces The Launch Of Barrigel™ Rectal Spacer In Japan As A Proven Safe And Effective Option To Minimize The Harmful Long-Term Side Effects Of Prostate Radiation Therapy
Aug 19 (Reuters) - Teleflex Inc TFX.N: TELEFLEX ANNOUNCES THE LAUNCH OF BARRIGEL™ RECTAL SPACER IN JAPAN AS A PROVEN SAFE AND EFFECTIVE OPTION TO MINIMIZE THE HARMFUL LONG-TERM SIDE EFFECTS OF PROSTATE RADIATION THERAPY TELEFLEX INC - JAPANESE PMDA APPROVES BARRIGEL RECTAL SPACER FOR PROSTATE RADIATION THERAPY Source text: ID:nGNX2dmrQl Further company coverage: TFX.N ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Teleflex Incorporated
See all newsBrief: UK's CMA Issues Invitation to Comment on Intersurgical-Teleflex Transaction
Competition and Mkts - Merger Update: Intersurgical / Teleflex
Teleflex Incorporated reports results for the quarter ended June 30 - Earnings Summary
Teleflex Q2 revenue rises 29%, beats analyst estimates
US FDA approves first freeze-dried plasma product (updated)